Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmacy “Fee-For-Service” Model Could Aid Chronic-Use OTC Switches

This article was originally published in The Tan Sheet

Executive Summary

A pharmacy "fee-for-service" model could create a "de facto third class" of drugs that would facilitate over-the-counter switches for chronic-use medications, SDM, Inc. President Bill Howard, PhD, suggested at an IIR conference on Rx-to-OTC switches in Philadelphia Nov. 20

You may also be interested in...



OTC Drug Spending By Some Insurers Hindered By Antitrust Law

Statutory caps on nonprescription drug spending by not-for-profit insurers could pose a significant barrier to expanded use of over-the-counter products

OTC Drug Spending By Some Insurers Hindered By Antitrust Law

Statutory caps on nonprescription drug spending by not-for-profit insurers could pose a significant barrier to expanded use of over-the-counter products

OTC Drug Spending By Some Insurers Hindered By Antitrust Law

Statutory caps on nonprescription drug spending by not-for-profit insurers could pose a significant barrier to expanded use of over-the-counter products

Related Content

Topics

UsernamePublicRestriction

Register

LL005491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel